The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
出版年份 2017 全文链接
标题
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
作者
关键词
-
出版物
Frontiers in Immunology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-05-31
DOI
10.3389/fimmu.2017.00631
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
- (2017) Maria Carmen Ochoa et al. IMMUNOLOGY AND CELL BIOLOGY
- In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
- (2017) John P. Veluchamy et al. Frontiers in Immunology
- Évaluation de l’expression de PD-L1 en immunohistochimie : un biomarqueur émergent dans les carcinomes pulmonaires non à petites cellules
- (2016) Julien Adam et al. ANNALES DE PATHOLOGIE
- Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation
- (2016) Brian C. Shaffer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell–Replete Allogeneic Hematopoietic Stem Cell Transplantation
- (2016) Lia Minculescu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
- (2016) Dean A. Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia
- (2016) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
- (2016) John P. Veluchamy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
- (2016) A. Curti et al. CLINICAL CANCER RESEARCH
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
- (2016) Jesus I. Luna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
- (2016) Peter S. Kim et al. Oncotarget
- A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
- (2016) Xilin Chen et al. Oncotarget
- Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
- (2016) Hiroki Torikai et al. Scientific Reports
- Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
- (2016) T. Kamiya et al. Cancer Immunology Research
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
- (2015) A. Rothe et al. BLOOD
- The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
- (2015) M. Rosario et al. CLINICAL CANCER RESEARCH
- Cord blood: a promising source of allogeneic natural killer cells for immunotherapy
- (2015) Hila Shaim et al. CYTOTHERAPY
- Bispecific antibodies
- (2015) Roland E. Kontermann et al. DRUG DISCOVERY TODAY
- Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
- (2015) Dimitrios Mathios et al. INTERNATIONAL JOURNAL OF CANCER
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Natural killer cell therapy in children with relapsed leukemia
- (2015) Jeffrey E. Rubnitz et al. PEDIATRIC BLOOD & CANCER
- NK cell exhaustion: bad news for chronic disease?
- (2015) Jamie L. Schafer et al. Oncotarget
- CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
- (2015) Aldo M. Roccaro et al. Cell Reports
- Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
- (2015) P. R. Rhode et al. Cancer Immunology Research
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
- (2015) Valentin Goede et al. Oncology Research and Treatment
- NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
- (2015) Jinyu Zhang et al. Frontiers in Immunology
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
- (2015) Mattias Carlsten et al. Frontiers in Immunology
- Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
- (2015) Panagiotis D. Kottaridis et al. PLoS One
- Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
- (2014) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
- (2014) N. N. Shah et al. BLOOD
- NOX-A12: mobilizing CLL away from home
- (2014) R. Marasca et al. BLOOD
- Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
- (2014) V. Bachanova et al. BLOOD
- Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy
- (2014) D E Oppenheim et al. BRITISH JOURNAL OF CANCER
- Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation
- (2014) Monica Killig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
- (2014) Michinori Ogura et al. JOURNAL OF CLINICAL ONCOLOGY
- Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
- (2014) Carolyn M Cheney et al. mAbs
- Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
- (2014) Sawa Ito et al. MOLECULAR THERAPY
- Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
- (2014) Evan Gomes-Giacoia et al. PLoS One
- ROR1, an embryonic protein with an emerging role in cancer biology
- (2014) Nicholas Borcherding et al. Protein & Cell
- Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
- (2013) H. Torikai et al. BLOOD
- Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
- (2013) W. Xu et al. CANCER RESEARCH
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma
- (2013) Jean-Pierre Delord et al. EUROPEAN JOURNAL OF CANCER
- Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody
- (2013) Ge Zhang et al. IMMUNOLOGY AND CELL BIOLOGY
- DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
- (2013) Lucas Ferrari de Andrade et al. IMMUNOLOGY AND CELL BIOLOGY
- Natural cytotoxicity receptors and their ligands
- (2013) Philip H Kruse et al. IMMUNOLOGY AND CELL BIOLOGY
- Natural killer cell biology: An update and future directions
- (2013) Kerry S. Campbell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
- (2013) James D Mellor et al. Journal of Hematology & Oncology
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
- (2013) Okjae Lim et al. PLoS One
- Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
- (2013) Jeannette Cany et al. PLoS One
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Therapeutic applications: natural killer cells in the clinic
- (2013) J. S. Miller Hematology-American Society of Hematology Education Program
- Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
- (2013) Laurent Boissel et al. OncoImmunology
- Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
- (2013) Caroline Sola et al. Journal for ImmunoTherapy of Cancer
- Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
- (2012) S. Gill et al. BLOOD
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
- (2012) Christiane Sahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Ex Vivo Generated Natural Killer Cells Acquire Typical Natural Killer Receptors and Display a Cytotoxic Gene Expression Profile Similar to Peripheral Blood Natural Killer Cells
- (2012) Dorit Lehmann et al. STEM CELLS AND DEVELOPMENT
- Natural killer cells: a review of manufacturing and clinical utility
- (2012) Scott A. Koepsell et al. TRANSFUSION
- Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions
- (2012) Hans Klingemann et al. TRANSFUSION
- T-cell depletion in GVHD: less is more?
- (2011) J. H. Antin BLOOD
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
- (2011) Claudia Brehm et al. PLoS One
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
- (2011) M. Gooden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-15 biology and its therapeutic implications in cancer
- (2011) Jason C. Steel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation
- (2010) David A. Rizzieri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Activating and inhibitory receptors of natural killer cells
- (2010) Hollie J Pegram et al. IMMUNOLOGY AND CELL BIOLOGY
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- New views on natural killer cell-based immunotherapy for melanoma treatment
- (2010) Shannon Burke et al. TRENDS IN IMMUNOLOGY
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
- (2009) S R Yoon et al. BONE MARROW TRANSPLANTATION
- 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells
- (2009) B. Altvater et al. CLINICAL CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
- (2008) Jumei Shi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now